U.S. Personal Products Stock News

CF Industries Holdings (NYSE:CF) just received a 'BBB' rating and stable outlook from Fitch for its proposed senior unsecured notes. The company plans to use the proceeds to refinance existing debt and invest in clean energy projects. See our latest analysis for CF Industries Holdings. The market’s response to CF Industries Holdings in 2024 has been muted, with the share price returning -8.5% year-to-date and total shareholder return down 10.4% over the past year. While strategic investments...

Earlier this week, Warner Music Group announced a landmark settlement with Udio, resolving copyright litigation and creating a licensing framework for Udio’s AI music platform launching in 2026, while also unveiling a new partnership with Stability AI to develop responsible, professionally focused AI music tools for creators. These developments highlight Warner Music’s leadership in integrating artificial intelligence collaboratively within the music industry, establishing new artist income...

Neurocrine Biosciences recently announced the publication of a comprehensive peer-reviewed review consolidating clinical and pharmacologic data on FDA-approved VMAT2 inhibitors used to treat tardive dyskinesia, emphasizing that INGREZZA® and deutetrabenazine are not interchangeable. This review highlights the distinct dosing, safety, and clinical profiles of each drug, providing important context for physicians and patients managing tardive dyskinesia. With clinical distinctions between...

Akamai Technologies (AKAM) recently caught the attention of investors after its stock moved up nearly 2% over the past week. The price shift comes as traders keep an eye on broader tech market dynamics and sector sentiment. See our latest analysis for Akamai Technologies. After a tough start to the year, Akamai’s share price has rebounded with an 18.6% gain over the past month, signaling renewed momentum following recent tech sector shifts. However, its one-year total shareholder return...

On November 20, 2025, Alphatec Holdings’ General Counsel, Marshall Tyson Eliot, sold 70,000 shares following the company’s strong third-quarter earnings, highlighted by substantial growth in surgical and EOS imaging technology revenue. This mix of robust revenue performance and executive share sales presents an interesting situation for stakeholders weighing short-term leadership actions against continued business momentum. We’ll look at how the impressive third-quarter revenue growth may...

In the third quarter of 2025, General Motors reported an 8% year-over-year increase in vehicle deliveries, lifted its full-year outlook, and highlighted gains across its truck, SUV, and electric vehicle segments, while also instructing suppliers to phase out sourcing from China by 2027. Rising OnStar fleet subscriptions, expanding digital services, and the pursuit of a North American supply chain reveal GM’s emphasis on recurring revenue and long-term resilience. We will explore how GM’s...

Ever wondered if Advanced Micro Devices is really worth its price tag, or if there's hidden value the market hasn't noticed yet? The stock has had a wild ride, soaring 68.9% year-to-date, but recently pulled back with a 17.4% drop in the last week and a 19.4% slide over the past month. Headlines have been buzzing about AMD's latest moves in AI chips and partnerships with major cloud providers, which many believe are fueling both excitement and volatility. Recent regulatory discussions around...

Ever wondered if Alkermes is a hidden gem or if it has already been discovered by the market? This deep dive will shed light on where the value may lie for curious investors. Alkermes' stock price has pulled back slightly, down 4.0% over the last month and hovering just below flat on a one-year view. However, it has still posted a strong 57.2% gain over the past five years. Much of this recent price movement has come alongside a wave of industry-wide shifts in biotech sentiment and increased...

Costco Wholesale (COST) just wrapped its fiscal quarter with solid gains in net sales and growing membership income, powered by its trademark low-margin, high-volume approach. Still, the stock is under pressure after recent declines, which draws fresh questions about its elevated valuation compared to future growth prospects. See our latest analysis for Costco Wholesale. Costco’s latest retail wins and solid membership growth are promising, yet the share price has fallen over 15% since...

TransDigm Group recently announced its fourth quarter and full-year results for fiscal 2025, reporting increased sales of US$2.44 billion and US$8.83 billion respectively, along with higher net income and earnings per share compared to the prior year. The company also completed another tranche of its ongoing share buyback program and issued fiscal 2026 guidance projecting revenue growth, but expects a modest decline in net income due to increased interest expenses from recent financing...

Tenet Healthcare (THC) recently completed a major debt refinancing by raising $1.5 billion in senior secured first lien notes and $750 million in senior notes. The fresh capital enables Tenet to redeem higher-cost obligations, improving its balance sheet and near-term flexibility. See our latest analysis for Tenet Healthcare. Following the refinancing news, Tenet Healthcare continues to attract attention for its robust performance. The stock’s 53.3% year-to-date share price return and...

VNET Group, Inc. recently raised its full-year 2025 revenue guidance to between RMB 9.55 billion and RMB 9.87 billion, projecting year-over-year growth of 16% to 19%, following strong third-quarter results driven by a surge in wholesale internet data center (IDC) business revenues and significant wholesale customer orders. This uptick in guidance reflects higher-than-expected customer move-ins, operational efficiency gains, and intensified investments to capture ongoing AI-driven demand for...

A new securities class action lawsuit has put Fiserv (FISV) in the spotlight, as investors react to allegations that management provided false signals on growth and financial outlook. Shares dropped sharply following the announcement. See our latest analysis for Fiserv. Fiserv’s legal woes arrive amid one of its most turbulent years yet, with the stock dropping 44% in a single session after slashing forecasts and revealing weaker results. Over the longer term, momentum has sharply faded, as...

Oscar Health recently announced the upcoming launch of affordable, tech-powered health plans and innovative services, including AI-driven support and a first-of-its-kind menopause offering, for individuals, families, and businesses across Southern Florida for the 2026 Open Enrollment period. This expansion broadens Oscar’s reach in key Florida markets and introduces personalized virtual care features such as the new Oswell health AI agent and targeted programs for chronic conditions and...

Lululemon athletica inc. recently announced the departure of Celeste Burgoyne, President of the Americas and Global Guest Innovation, and the immediate appointment of André Maestrini as President and Chief Commercial Officer, consolidating global leadership roles. This executive transition occurs as the company continues to face operational pressures, including slowing growth in the Americas, heightened competition, and evolving consumer preferences. We'll examine how this significant...

Ameris Bancorp (ABCB) has recently caught attention as analyst sentiment toward the company improves and expectations for future earnings become more positive. This shift stands out in an otherwise underperforming industry. See our latest analysis for Ameris Bancorp. Ameris Bancorp’s share price has climbed 21.6% year-to-date, reflecting renewed momentum as sentiment improves and confidence grows in its outlook. Over the longer term, the company has delivered a 124.5% total shareholder return...

WisdomTree (WT) shares climbed around 2% in the latest session, drawing interest after recent trading activity. Investors are now watching the stock's ongoing price action, particularly in light of the broader trends in financial sector performance. See our latest analysis for WisdomTree. Zooming out, WisdomTree’s latest price swing follows a period of notable volatility. While the share price has climbed more than 8% so far this year, recent weeks saw a pullback and overall, the past twelve...

Edison International (EIX) shares have moved slightly in recent sessions, catching the eye of investors who are watching for shifts in the utility sector. The company’s performance over the past month offers some interesting signals for its outlook. See our latest analysis for Edison International. Zooming out, Edison International’s share price has seen a modest pickup over the last month. However, long-term momentum has clearly faded, with a 1-year total return of -28.29%. While the latest...

Recent news has spotlighted Federal National Mortgage Association (Fannie Mae) as reform proposals and regulatory scrutiny shape the outlook for the government-sponsored mortgage giant. High-profile investor commentary on IPO timing and ongoing investigations into the Federal Housing Finance Agency have heightened uncertainty for Fannie Mae's future structure and regulatory environment. We’ll explore how renewed discussions on Fannie Mae’s IPO process and regulatory attention impact the...

American Assets Trust (AAT) shares have shown muted performance lately, with the stock down 4% over the past month and nearly 27% over the past year. Investors may be weighing ongoing sector headwinds as they evaluate the company’s steady revenue growth. See our latest analysis for American Assets Trust. After a rough 12 months, American Assets Trust’s share price has seen momentum fade. Its year-to-date price return sits at -26.4% and the one-year total shareholder return is -27.5%. This...

Analog Devices (ADI) is set to report its latest quarterly earnings next week, and there is plenty for investors to consider. Projections call for meaningful increases in both earnings per share and revenue compared to last year, with growth expected across multiple segments. See our latest analysis for Analog Devices. The upcoming earnings announcement and recent investor events appear to be fueling fresh optimism around Analog Devices, as reflected in its year-to-date share price return of...

Earlier this month, ORIC Pharmaceuticals announced additional efficacy and safety results from its Phase 1b trial of ORIC-944 in combination with androgen receptor inhibitors in patients with metastatic castration-resistant prostate cancer, highlighting promising PSA and ctDNA responses alongside a favorable safety profile. Many patients in the study had received multiple prior treatments, yet ORIC-944 showed robust antitumor activity, positioning the compound as a potential new option in a...

Wondering if CenterPoint Energy stock is truly a solid value pick right now? You are not alone, as many investors are re-examining utility stocks in this evolving market environment. Despite a relatively flat month with a 0.1% gain, CenterPoint Energy has posted an impressive 25.6% return year-to-date and is up 87.0% over five years. This hints at both strong growth potential and shifting risk perceptions. News of ongoing infrastructure investments and regulatory developments has provided...

In recent days, Reddit gained attention after several analysts reiterated a positive outlook and highlighted company advances such as improved user engagement, AI-powered features, and new advertising formats like Interactive Ads. This wave of commentary coincided with Reddit CEO Steve Huffman selling US$3.5 million of shares under a prearranged plan and ARK Invest reducing its exposure, underscoring heightened institutional activity around the stock. To understand the effect of these...